Department of Error: Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study (The Lancet (2020) 395(10225) (689–697), (S0140673620302609), (10.1016/S0140-6736(20)30260-9));Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study

The Lancet

Volumn 395, Issue 10225, 2020, Pages 689-697

  Wu, Joseph T ^a   Leung, Kathy ^a   Leung, Gabriel M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASIC REPRODUCTION NUMBER; CHINA; CONTROLLED STUDY; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; DISEASE TRANSMISSION; EPIDEMIC; FORECASTING; HUMAN; INCIDENCE; INCUBATION TIME; INTERVENTION STUDY; MARKOV CHAIN MONTE CARLO METHOD; METAPOPULATION; MONTE CARLO METHOD; NOWCASTING AND FORECASTING; PREVALENCE; PRIORITY JOURNAL; QUARANTINE; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SIMULATION; COMPUTER SIMULATION; HOSPITALIZATION; INTERNATIONAL COOPERATION; MARKOV CHAIN;

CHINA; COMPUTER SIMULATION; CORONAVIRUS INFECTIONS; EPIDEMICS; FORECASTING; HOSPITALIZATION; HUMANS; INFECTIOUS DISEASE INCUBATION PERIOD; INTERNATIONALITY; MARKOV CHAINS; MONTE CARLO METHOD; PREVALENCE;

EID: 85078864717     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(20)30302-0     Document Type: Erratum

References (46)

1. Lloyd-Smith, JO, Schreiber, SJ, Kopp, PE, Getz, WM, Superspreading and the effect of individual variation on disease emergence. Nature 438 (2005), 355–359.
2. Chowell, G, Castillo-Chavez, C, Fenimore, PW, Kribs-Zaleta, CM, Arriola, L, Hyman, JM, Model parameters and outbreak control for SARS. Emerg Infect Dis 10 (2004), 1258–1263.
3. Riley, S, Fraser, C, Donnelly, CA, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 300 (2003), 1961–1966.
4. Lipsitch, M, Cohen, T, Cooper, B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 300 (2003), 1966–1970.
5. Chowell, G, Abdirizak, F, Lee, S, et al. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med, 13, 2015, 210.
6. Kucharski, AJ, Althaus, C, The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission. Euro Surveill 20 (2015), 14–18.
7. Cauchemez, S, Nouvellet, P, Cori, A, et al. Unraveling the drivers of MERS-CoV transmission. Proc Natl Acad Sci USA 113 (2016), 9081–9086.
8. Park, J-E, Jung, S, Kim, A, Park, JE, MERS transmission and risk factors: a systematic review. BMC Public Health, 18, 2018, 574.
9. Walsh, EE, Shin, JH, Falsey, AR, Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations. J Infect Dis 208 (2013), 1634–1642.
10. Zhang, SF, Tuo, JL, Huang, XB, et al. Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou. PLoS One, 13, 2018, e0191789.
11. Gaunt, ER, Hardie, A, Claas, EC, Simmonds, P, Templeton, KE, Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol 48 (2010), 2940–2947.
12. Leung, GM, Hedley, AJ, Ho, LM, et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med 141 (2004), 662–673.
13. Lau, EH, Hsiung, CA, Cowling, BJ, et al. A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan. BMC Infect Dis, 10, 2010, 50.
14. Virlogeux, V, Fang, VJ, Park, M, Wu, JT, Cowling, BJ, Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia. Sci Rep, 6, 2016, 35839.
15. Vijgen, L, Keyaerts, E, Moës, E, et al. Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J Virol 79 (2005), 1595–1604.
16. Lessler, J, Reich, NG, Brookmeyer, R, Perl, TM, Nelson, KE, Cummings, DA, Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 9 (2009), 291–300.
17. Mason, R, Broaddus, VC, Martin, T, et al. Murray and Nadel's textbook of respiratory medicine, 5th edn., 2010, Elsevier, Amsterdam.
18. Cowling, BJ, Park, M, Fang, VJ, Wu, P, Leung, GM, Wu, JT, Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill 20 (2015), 7–13.
19. Leung, GM, Lim, WW, Ho, LM, et al. Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. Epidemiol Infect 134 (2006), 211–221.
20. Al Kahlout, RA, Nasrallah, GK, Farag, EA, et al. Comparative serological study for the prevalence of anti-MERS coronavirus antibodies in high-and low-risk groups in Qatar. J Immunol Res, 2019 published online Feb 18. DOI: 10.1155/2019/1386740.
21. Abbad, A, Perera, RA, Anga, L, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018. Euro Surveill, 24, 2019, 1900244.
22. Gill, EP, Dominguez, EA, Greenberg, SB, et al. Development and application of an enzyme immunoassay for coronavirus OC43 antibody in acute respiratory illness. J Clin Microbiol 32 (1994), 2372–2376.
23. Chan, CM, Tse, H, Wong, SS, et al. Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus. J Clin Virol 45 (2009), 54–60.
24. Oh, MD, Park, WB, Park, SW, et al. Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea. Korean J Intern Med 33 (2018), 233–246.
25. Patrick, DM, Petric, M, Skowronski, DM, et al. An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus. Can J Infect Dis Med Microbiol 17 (2006), 330–336.
26. Matsuno, AK, Gagliardi, TB, Paula, FE, et al. Human coronavirus alone or in co-infection with rhinovirus C is a risk factor for severe respiratory disease and admission to the pediatric intensive care unit: a one-year study in Southeast Brazil. PLoS One, 14, 2019, e0217744.
27. Jia, N, Feng, D, Fang, LQ, et al. Case fatality of SARS in mainland China and associated risk factors. Trop Med Int Health 14:suppl 1 (2009), 21–27.
28. Breban, R, Riou, J, Fontanet, A, Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 382 (2013), 694–699.
29. Cauchemez, S, Fraser, C, Van Kerkhove, MD, et al. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis 14 (2014), 50–56.
30. Hung, LS, The SARS epidemic in Hong Kong: what lessons have we learned?. J R Soc Med 96 (2003), 374–378.
31. McDonald, LC, Simor, AE, Su, IJ, et al. SARS in healthcare facilities, Toronto and Taiwan. Emerg Infect Dis 10 (2004), 777–781.
32. People's Daily Online. Wuhan is expected to send 15 million passengers during Spring Festival in 2020 (in Chinese). http://hb.people.com.cn/n2/2019/1228/c194063-33671662.html, Dec 28, 2019. (Accessed 2 January 2020)
33. The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team Li, Q, An outbreak of NCIP (2019-nCoV) infection in China—Wuhan, Hubei Province, 2019–2020. China CDC Weekly 2 (2020), 79–80.
34. Li, Q, Guan, X, Wu, P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 2020 published online Jan 29. DOI: 10.1056/NEJMoa2001316.
35. Wang, L, Wu, JT, Characterizing the dynamics underlying global spread of epidemics. Nat Commun, 9, 2018, 218.
36. Bootsma, MC, Ferguson, NM, The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc Natl Acad Sci USA 104 (2007), 7588–7593.
37. Centers for Disease Control and Prevention. Frequently asked questions about SARS. https://www.cdc.gov/sars/about/faq.html, 2005. (Accessed 25 January 2020)
38. Diekmann, O, Heesterbeek, JAP, Mathematical epidemiology of infectious diseases: model building, analysis and interpretation, 2000, John Wiley, Chichester.
39. Desai, AN, Kraemer, MUG, Bhatia, S, et al. Real-time epidemic forecasting: challenges and opportunities. Health Secur 17 (2019), 268–275.
40. Polonsky, JA, Baidjoe, A, Kamvar, ZN, et al. Outbreak analytics: a developing data science for informing the response to emerging pathogens. Philos Trans R Soc Lond B Biol Sci, 374, 2019, 20180276.
41. Lipsitch, M, Finelli, L, Heffernan, RT, Leung, GM, Redd, SC, Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1. Biosecur Bioterror 9 (2011), 89–115.
42. Imai, N, Cori, A, Dorigatti, I, et al. MRC Centre for Global Infectious Disease Analysis: Wuhan coronavirus reports 1–3. https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news–wuhan-coronavirus, January, 2020. (Accessed 25 January 2020)
43. Read, JM, Bridgen, JRE, Cummings, DAT, Ho, A, Jewell, CP, Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. medRxiv, 2020 published online Jan 24. DOI: 10.1101/2020.01.23.20018549 (preprint).
44. Liu, T, Hu, J, Kang, M, et al. Transmission dynamics of 2019 novel coronavirus (2019-nCoV). bioRxiv, 2020 published online Jan 26. DOI: 10.1101/2020.01.25.919787 (preprint).
45. Zhao, S, Ran, J, Musa, SS, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. bioRxiv, 2020 published online Jan 24. DOI: 10.1101/2020.01.23.916395 (preprint).
46. State Administration for Market Regulation. Announcement of the State Administration of Market Supervision, Ministry of Agriculture and Rural Affairs, and the National Forestry and Grass Bureau on banning wildlife trading (in Chinese). http://gkml.samr.gov.cn/nsjg/wjs/202001/t20200126_310742.html, Jan 26, 2020. (Accessed 25 January 2020)